PWM
IBB icon

Perigon Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Perigon Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$328K Sell
1,944
-790
-29% -$135K 0.01% 984
2025
Q4 		$461K Buy
2,734
+333
+14% +$54.1K 0.01% 839
2025
Q3 		$347K Sell
2,401
-239
-9% -$32.6K 0.01% 889
2025
Q2 		$334K Hold
2,640
– – 0.01% 807
2025
Q1 		$338K Sell
2,640
-44
-2% -$5.97K 0.01% 768
2024
Q4 		$357K Sell
2,684
-931
-26% -$131K 0.01% 757
2024
Q3 		$526K Buy
3,615
+21
+0.6% +$3.04K 0.01% 604
2024
Q2 		$493K Sell
3,594
-5,669
-61% -$757K 0.01% 537
2024
Q1 		$1.27M Buy
9,263
+2,507
+37% +$342K 0.04% 315
2023
Q4 		$918K Buy
6,756
+706
+12% +$86.1K 0.03% 358
2023
Q3 		$740K Sell
6,050
-94
-2% -$12K 0.03% 363
2023
Q2 		$780K Buy
6,144
+43
+0.7% +$5.59K 0.03% 362
2023
Q1 		$788K Sell
6,101
-396
-6% -$51.8K 0.04% 314
2022
Q4 		$853K Buy
6,497
+3,256
+100% +$421K 0.05% 296
2022
Q3 		$379K Hold
3,241
– – 0.03% 378
2022
Q2 		$381K Sell
3,241
-93
-3% -$11K 0.03% 377
2022
Q1 		$434K Sell
3,334
-488
-13% -$63.6K 0.03% 388
2021
Q4 		$583K Buy
3,822
+89
+2% +$13.8K 0.04% 307
2021
Q3 		$604K Hold
3,733
– – 0.05% 273
2021
Q2 		$611K Sell
3,733
-12
-0.3% -$1.85K 0.05% 267
2021
Q1 		$564K Sell
3,745
-141
-4% -$22.4K 0.06% 264
2020
Q4 		$589K Buy
3,886
+22
+0.6% +$3.14K 0.07% 220
2020
Q3 		$523K Sell
3,864
-42
-1% -$5.7K 0.07% 213
2020
Q2 		$534K Buy
3,906
+261
+7% +$33.3K 0.08% 191
2020
Q1 		$415K Buy
3,645
+663
+22% +$76.3K 0.08% 192
2019
Q4 		$355K Buy
2,982
+590
+25% +$65.8K 0.07% 175
2019
Q3 		$245K Sell
2,392
-3,046
-56% -$319K 0.06% 200
2019
Q2 		$593K Sell
5,438
-3,250
-37% -$346K 0.14% 111
2019
Q1 		$927K Sell
8,688
-300
-3% -$32.9K 0.22% 79
2018
Q4 		$984K Buy
8,988
+1,062
+13% +$113K 0.25% 70
2018
Q3 		$967K Buy
+7,926
New +$933K 0.24% 77
2018
Q2 		– Sell
-600
Closed -$64K – 411
2018
Q1 		$64K Hold
600
– – 0.02% 286
2017
Q4 		$64K Hold
600
– – 0.02% 262
2017
Q3 		$67K Hold
600
– – 0.02% 302
2017
Q2 		$62K Hold
600
– – 0.01% 360
2017
Q1 		$59K Sell
600
-165
-22% -$15.8K 0.01% 373
2016
Q4 		$77K Buy
765
+165
+28% +$15K 0.02% 313
2016
Q3 		$58K Hold
600
– – 0.01% 292
2016
Q2 		$51K Buy
+600
New +$53.8K 0.01% 280

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Perigon Wealth Management's IBB Position: Q1 2026 in Review

Perigon Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 29% in Q1 2026, selling an estimated $135K and leaving 1,944 shares worth $328K. The position accounts for 0.01% of the portfolio, ranked #984.

Perigon Wealth Management first reported a position in IBB in Q2 2016 and has held it in 39 quarters since. The position peaked at $1.27M in Q1 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Perigon Wealth Management held 1,944 shares of iShares Biotechnology ETF worth $328K as of Q1 2026.
  • Perigon Wealth Management sold 790 iShares Biotechnology ETF shares in Q1 2026, an estimated $135K.
  • iShares Biotechnology ETF made up 0.01% of Perigon Wealth Management's portfolio in Q1 2026, its #984 holding.
  • Perigon Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 39 quarters since.
  • Perigon Wealth Management's iShares Biotechnology ETF position peaked at $1.27M in Q1 2024.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.